Vera Health has secured $28.5 million in Series A funding to accelerate the international expansion of its AI-powered clinical search platform, bringing its total funding to $32 million. The investment follows rapid adoption of the technology, which the company reports is now used by more than 800,000 clinicians across 190 countries.
Co-founded by Maxime Allouch and Taieb Bennani, Vera Health provides an evidence-based clinical search engine designed to help healthcare professionals access and evaluate medical research. The platform searches more than 60 million scientific publications, clinical guidelines, consensus statements, and drug labels to generate responses supported by verifiable sources.
Unlike general-purpose AI systems, Vera retrieves relevant medical evidence before generating answers, linking claims directly to their sources and using colour-coded indicators to communicate the strength and limitations of supporting research.
Bennani explained the company's approach: “Language models are built to sound certain; medicine rarely is. A general-purpose model produces plausible sentences, but medicine requires verifiable ones. So we built Vera the other way around: it finds the evidence first, and only then writes the answer. In essence, it’s a search engine that reasons like a clinician.”
The company reports substantial growth over the past year, expanding from several thousand users to more than 800,000 clinicians with a workforce of 12 employees. Adoption has been particularly notable in Europe, where approximately one in four physicians in Spain and Italy reportedly use the platform, alongside one in seven in France.
The new funding will support further development of Vera's evidence infrastructure, international recruitment, and partnerships with healthcare organisations. Its expansion strategy prioritises localisation, adapting clinical responses to national guidelines, languages, and healthcare practices.
The investment comes amid increasing competition in AI-enabled clinical decision support, with platforms including OpenEvidence, Doximity Ask, Elsevier's ClinicalKey, and Wolters Kluwer's UpToDate addressing similar information needs.
While Vera's reported adoption indicates growing demand for AI-assisted medical research, further evidence will be needed to establish its impact on clinical decision-making, sustained engagement, and patient outcomes.
Click here for the original news story.
